Physician profile
Robert E Mayle
NPI 1174710545
$299,734.71
in general payments reported to CMS, 2019-2025
6 companies · $79K in 2025
The $79K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $41K · 2021: $32K · 2022: $45K · 2023: $29K · 2024: $63K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $164K · Travel and Lodging: $5,565 · Food and Beverage: $1,951.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $163,549.09 |
| Travel and Lodging | $5,564.68 |
| Food and Beverage | $1,951.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $284,149.88 | 2019-2025 | Actis, Pinnacle, Velys |
| Depuy Synthes Products, INC. | $10,098.02 | 2025 | Actis, Pinnacle, Velys |
| Pacira Pharmaceuticals Incorporated | $4,167.52 | 2019-2025 | Zilretta, Iovera, Exparel |
| Depuy Synthes Sales INC. | $1,242.14 | 2019-2025 | Velys, Emphasys, Attune |
| Ethicon US, LLC | $39.47 | 2025 | Dermabond Prineo, Stratafix |
| Heron Therapeutics, INC. | $37.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mayle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.